Shen, Shih-Pei
Yan, Li
Wu, Tao
Huang, Min-Wei
Huang, Kuan-Chih
Qiu, Hong
Zhang, Yongjing
Tang, Chao-Hsiun http://orcid.org/0000-0003-0545-1567
Funding for this research was provided by:
Janssen Research and Development
Article History
Accepted: 21 March 2024
First Online: 15 April 2024
Declarations
:
: This work was supported by Janssen Research & Development LLC (Titusville, NJ, USA).
: The authors declare the following conflicts of interest. Li Yan, Tao Wu, Kuan-Chih Huang, Hong Qiu, and Yongjing Zhang are employees of Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson. Hong Qiu and Yongjing Zhang report stock ownership in Johnson & Johnson. Shih-Pei Shen, Min-Wei Huang, and Chao-Hsiun Tang declare no conflicts of interest.
: The data underlying this study are from the National Health Insurance Research Database, which has been transferred to the Health and Welfare Data Science Center (HWDC). The Taiwan government prohibits the release of the NHI claims dataset to the public domain. Interested researchers can obtain the data through formal application to the HWDC, Department of Statistics, Ministry of Health and Welfare, Taiwan ().
: De-identified aggregated patient data were used for the analysis. This study was granted an exemption from ethical review by the Taipei Medical University-Joint Institutional Review Board and an exemption from the need for patient consent. The study was conducted according to all applicable guidelines and regulations.
: Not applicable.
: Not applicable.
: Not applicable.
: Data curation: CHT and SPS. Formal analysis: CHT and SPS. Data interpretation: MWH. Manuscript review and editing: All authors. Methodology: LY, TW, HQ, YZ and CHT. Project administration: LY, TW, and KCH. Protocol writing: LY and TW. Study conceptualization: HQ, YZ and CHT. Supervision: HQ, YZ and CHT. All authors have reviewed and approved the final manuscript.